Consistently, 18% of the patients harbored genomic amplification of VEGFA, 4, 3, and 2 in CIN, GS, and EBV subtypes, respectively (Fig. 2c). The gene discussed is VEGFA; the disease is cervical squamous intraepithelial neoplasia.